Latest Close
$49.51
News
CRSP
CRISPR Therapeutics AG News
This news view pulls recent coverage and headlines tied to CRSP.
1y Change
$16.85 (+51.59%)
Market Cap
$4.75B
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Assessing CRISPR Therapeutics (CRSP) Valuation As Recent Returns Send Mixed Signals
Simply Wall St. • Apr 4, 2026
Read articleThe Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today
24/7 Wall St. • Apr 3, 2026
Read articleCRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts
Zacks • Apr 2, 2026
Read articleCRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider
Zacks • Apr 1, 2026
Read articleCRISPR (CRSP) Rated Overweight on Gene Editing Growth
Insider Monkey • Mar 31, 2026
Read articleIs CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Pullback?
Simply Wall St. • Mar 29, 2026
Read article